These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18284706)

  • 1. Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients.
    Cressey R; Pimpa S; Chewaskulyong B; Lertprasertsuke N; Saeteng S; Tayapiwatana C; Kasinrerk W
    BMC Biotechnol; 2008 Feb; 8():16. PubMed ID: 18284706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.
    Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J
    Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
    Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
    Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
    Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
    Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer.
    Ostendorff HP; Awad A; Braunschweiger KI; Liu Z; Wan Z; Rothschild KJ; Lim MJ
    J Immunol Methods; 2013 Dec; 400-401():58-69. PubMed ID: 24161315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
    Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
    Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with cervical cancer.
    Huangfu M; Xu S; Li S; Sun B; Lee KH; Liu L; Sun S
    Tumour Biol; 2016 Jul; 37(7):8709-14. PubMed ID: 26738866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.
    Looi K; Megliorino R; Shi FD; Peng XX; Chen Y; Zhang JY
    Oncol Rep; 2006 Nov; 16(5):1105-10. PubMed ID: 17016600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
    Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
    Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a panel of tumor-associated antigens in breast cancer.
    Pagaza-Straffon C; Marchat LA; Herrera L; Díaz-Chávez J; Avante MG; Rodríguez YP; Arreola MC; López-Camarillo C
    Cancer Biomark; 2020; 27(2):207-211. PubMed ID: 31839604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance and diagnostic value of Survivin autoantibody in non-small cell lung cancer patients].
    Ma L; Yue W; Zhang L; Wang Y; Zhang C; Yang X
    Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):706-12. PubMed ID: 20673487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
    Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
    J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 autoantibodies in patients with pancreatitis and pancreatic carcinoma.
    Raedle J; Oremek G; Welker M; Roth WK; Caspary WF; Zeuzem S
    Pancreas; 1996 Oct; 13(3):241-6. PubMed ID: 8884844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis.
    Høgdall EV; Høgdall CK; Blaakaer J; Heegaard NH; Glud E; Christensen L; Bock JE; Nørgaard-Pedersen B; Wiik A; Kjaer SK
    APMIS; 2002 Aug; 110(7-8):545-53. PubMed ID: 12390412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 antibodies in the sera of lung cancer patients: comparison with p53 mutation in the tumour tissue.
    Wild CP; Ridanpää M; Anttila S; Lubin R; Soussi T; Husgafvel-Pursiainen K; Vainio H
    Int J Cancer; 1995 Jun; 64(3):176-81. PubMed ID: 7622306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A highly sensitive particle agglutination assay for the detection of P53 autoantibodies in patients with lung cancer.
    Agaylan A; Binder D; Sauer M; Neuweiler H; Meyer O; Kiesewetter H; Salama A
    Cancer; 2007 Dec; 110(11):2502-6. PubMed ID: 17932907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.